Table 5.
Outcomes used in clinical trials for Alzheimer’s disease and mild cognitive impairment
Staging | Cognition | ADLs | Global |
---|---|---|---|
Mini-Mental State Examination (MMSE) | Alzheimer’s Disease Assessment Scale- cognitive subscale (ADAS-cog) | Alzheimer’s Disease Cooperative Study- Activities of Daily Living (ADCS-ADL) | Alzheimer’s Disease Cooperative Study- Clinical Global Impression of Change (ADCS-CGIC) |
Clinical Dementia Rating Scale (CDR) | Neuropsychological Test Battery (NTB) | Disability in Alzheimer’s Disease (DAD) | Clinical Dementia Rating Scale-sum of boxes (CDR-SB) |
Global Deterioration Scale (GDS) | Mini-Mental State Examination (MMSE) | Progressive Deterioration Scale (PDS) | Gottfries-Brane-Steen (GBS) |
Gottfries-Brane-Steen (GBS) | Severe Impairment Battery (SIB) | Bristol activities of daily living (ADL) |